Back
Rules Beco's Ads Against Products Fail Test
The has granted an restraining , which operates the home-care brand Beco, from continuing its ‘War on What’s Hidden’ advertising campaign that claimed ’s Surf Excel and Vim products cause skin irritation and allergic reactions. Justice Anup Jairam Bhambhani, presiding over the matter, orally remarked, “I am injuncting your ad campaign,” and subsequently issued a detailed order holding that the campaign crossed the permissible contours of .
The ruling came on an application filed by after Beco launched a multi-platform campaign across YouTube, Instagram, its website, and outdoor hoardings in several cities. The advertisements named ’s products and highlighted the presence of two chemicals—Linear Alkylbenzene Sulfonate (LAS) and Benzisothiazolinone (BIT)—asserting that these substances could cause skin irritation, redness, itching, or even eczema. The campaign urged consumers to “Switch to Beco,” positioning its own products as hypoallergenic, baby-safe, and pet-safe.
argued that the campaign constituted a textbook case of , going well beyond by directly telling consumers that its products are unsafe. , appearing for , submitted that Indian courts have long drawn a firm line: a company may boast that its own product is superior, but it cannot claim a rival’s product is harmful or unsafe. He contended that Beco’s claims were misleading because no tests had been conducted on ’s finished products—only on the presence of certain ingredients—and because the same ingredients are widely used across the industry, yet Beco singled out ’s brands.
Beco, represented by , defended the campaign as legitimate and consumer awareness, arguing that to a claim. Lall contended that the accuracy of the claims could only be conclusively tested at trial, not at the interim stage, and that restraining the entire campaign would disproportionately curtail the defendant’s protected under .
The Legal Framework for
Justice Bhambhani began by clarifying the legal standards governing . The court observed that , which portrays a party’s product as superior to a competitor’s and thereby shows the competitor’s product in a poor light, is not in and of itself offensive to the law. “Just because a comparative advertisement is derisive or denigrating or unflattering of the competitor’s product or service does not necessarily imply that it amounts to in law,” the court noted.
However, the court emphasised that is subject to a crucial caveat: it must not be based on statements that are not truthful, that misrepresent a state of affairs, or that are deceptive or misleading in their overall effect and impact. The court explained that truthful but unfavourable comparison cannot become actionable merely because the competitor considers it disparaging. For a comparative advertisement to amount to in law, it must involve falsehood, misrepresentation, or deception that causes injury to the competitor’s intellectual property or reputation.
The
A central aspect of the judgment was the court’s application of the “overall message” test. The court rejected the argument that individual statements in the advertisement should be assessed in isolation. “A particular element of an advertisement may, when viewed in isolation, be accurate or truthful, but when juxtaposed with its other elements, the advertisement viewed as a whole may convey a false and/or misleading and/or deceptive message to an ,” the court observed.
Applying this test, the court found that Beco’s campaign could not be dissected into standalone statements. While it might be true that LAS and BIT, taken on a standalone and isolated basis, can cause skin irritation and allergic reactions, and that ’s products contain some proportion of these chemicals, the advertisements did not present that information in isolation. Instead, the various formats of the campaign juxtaposed statements about the chemicals with visual and pictorial depictions of ’s products, along with emphatic calls to “Switch to Beco.”
The court held that “the unmistakable overall message that an would get is that, since the plaintiff’s products contain BIT and LAS, using them would cause skin irritation, including redness, itching, or even eczema.” The court reasoned that an , or any non-expert, would neither bother nor have the expertise to analyse or deconstruct the narrative, nor would they undertake a critical, scientific analysis of whether the statements are true when ’s products are used in the usual and ordinary way in daily life.
Findings and
The court declined to determine the competing scientific claims at the interim stage, noting that analysing laboratory reports and testing methodologies would require expert evidence at trial. However, the court found that the campaign’s use of complex chemical names, proportions, and percentages gave the viewer a sense of certitude that ’s products are risky to use. The adjoining panels placing ’s products alongside Beco’s, together with claims that Beco products are hypoallergenic, baby-safe, and pet-safe, betrayed the commercial motive of the campaign.
The court concluded that the impugned campaign falls foul of the caveats and qualifications governing . “In the opinion of this court, in doing so, the defendant crosses the permissible contours of ,” the order read. The court further held that had made out a case, that the lay in its favour, and that would be caused if Kwick Living were not restrained.
Order and Compliance
Justice Bhambhani directed Kwick Living to forthwith pull down, remove, and recall all advertisements that are the subject matter of the proceedings and contain the offending statements, across every format and medium, within one week. The company must also file an within one week thereafter. The court clarified that the restraint is limited to the impugned campaign and does not prevent Kwick Living from carrying out vis-à-vis ’s products otherwise, as long as it remains within permissible legal bounds.
Implications for Advertising Law
This judgment reinforces the well-established principle that must be judged by its overall impression on the , not by isolated technical truths. Legal professionals should note the court’s emphasis on the holistic impact of advertisements, especially when complex scientific claims are used to create an aura of certainty. The decision also underscores that truth is a defence only when the overall message is truthful and not misleading.
The case serves as a caution for brands engaging in comparative campaigns: highlighting a competitor’s ingredients without contextualising their safety in normal use can cross the line from into . The court’s willingness to grant an based on a finding of a misleading overall message signals that courts will scrutinise campaigns that directly attack a rival’s product safety, even if individual statements are technically accurate.
Conclusion
The ’s interim order in provides a clear reminder of the boundaries of in India. While healthy competition and truthful comparisons are encouraged, advertisements that convey a false or misleading overall message about a competitor’s product—especially one that suggests physical harm—will not be tolerated. The matter now proceeds to trial, where the scientific validity of Beco’s claims will be tested. For now, the injunction stands, and Beco must withdraw its campaign or face further legal consequences.
